Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|January 18, 2005
Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphomaRichard J Klasa
Antisense & Nucleic Acid Drug Development|August 7, 2002
Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatmentRichard J Klasa, Amanda M Gillum, Robert E Klem, et al.
Leukemia & Lymphoma|October 23, 2002
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II studyNicol Macpherson, Richard J Klasa, Randy Gascoyne, et al.
American Journal of Hematology|July 12, 2002
Cytogenetic findings in reactive lymphoid hyperplasia: significance of non-clonal t(3;14) and t(3;22)Wing Y Au, Douglas E Horsman, Joseph M Connors, et al.
International Journal of Pharmaceutics|June 28, 2002
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cellsEllen K Wasan, Dawn Waterhouse, Olena Sivak, et al.
Leukemia & Lymphoma|May 27, 2004
The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive casesWing Y Au, Douglas E Horsman, Randy D Gascoyne, et al.
Leukemia & Lymphoma|August 3, 2002
Cytogenetic analysis in mantle cell lymphoma: a review of 214 casesWing Y Au, Randy D Gascoyne, David S Viswanatha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimenRichard J Klasa, Ralph M Meyer, Chaim Shustik, et al.
British Journal of Haematology|August 22, 2003
Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcomeValia S Lestou, Randy D Gascoyne, Laurie Sehn, et al.
Molecular Cancer Therapeutics|April 1, 2008
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levelsCatherine A Tucker, Anita I Kapanen, Ghania Chikh, et al.
Pageof 2